and in vivo.
Aims and Objectives: To examine system
hemostatic activity of first synthesized benzylammonium
URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) activated TEG, in vitro
hemostatic system hyperactivity modeling was carried out with the blood of healthy
Because of the problem to evaluate biological
activity in water‑soluble substances in
all phases
-crown-6 ether in toluene. In vitro anticoagulant and antiplatelet
activity of the adduct was studied
Faizullina, L. Kh.,
Karamisheva, L. Sh.,
Yakupova, L. R.,
Migranov, A. R.,
Saifullin, R. L.,
Valeev, F. A.,
Valiullina, Z. A.,
Samorodov, A. V. (2024) synthesized in one step. The antioxidant, anticoagulation, and antiaggregation
activities of the obtained
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022)
studies of the antiplatelet, anticoagulant, and antioxidant
activity revealed promising compounds
Sultanova, .R.M,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Zlotsky, S.S.,
Valiullina, Z.A.,
Karamova, E.V.,
Samorodov, A.V. (2024) The main goal of applying antiplatelet drugs is a reduced probability of thrombosis so that
active synthesized by reaction of III with organic and inorganic bases. Compounds possessing antiaggregant
activityKhaliullin, F.A.,
Shabalina, Y.V.,
Samorodov, A.V.,
Kamilov, F.K.,
Timirkhanova, G.A.,
Murataev, D.Z. (2018) spectroscopy data. The compounds synthesized here had potentially high antiaggregatory
activity.